These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2857062)

  • 21. Dopaminergic modulation of physiological and pathological neurohumoral activation in man.
    Smit AJ; Lieverse AG; van Veldhuisen D; Girbes AR
    Hypertens Res; 1995 Jun; 18 Suppl 1():S107-11. PubMed ID: 8529037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs.
    Cannon PJ
    Am J Med; 1986 Aug; 81(2B):123-32. PubMed ID: 3092662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurohumoral mechanisms in cardiocirculatory decompensation].
    Grassi G; Mancia G
    Ann Ital Med Int; 1994 Oct; 9 Suppl():61S-67S. PubMed ID: 7857760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure.
    Goldsmith SR; Francis GS; Levine TB; Cowley AW; Cohn JN
    J Am Coll Cardiol; 1983 Dec; 2(6):1080-3. PubMed ID: 6355240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance.
    Hirsch AT; Dzau VJ; Creager MA
    Circulation; 1987 May; 75(5 Pt 2):IV36-48. PubMed ID: 2882866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.
    Levine TB; Francis GS; Goldsmith SR; Simon AB; Cohn JN
    Am J Cardiol; 1982 May; 49(7):1659-66. PubMed ID: 7044086
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurohumoral aspects of heart failure.
    Benedict CR
    Cardiol Clin; 1994 Feb; 12(1):9-23. PubMed ID: 7910114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroendocrine changes in chronic cardiac insufficiency].
    Jaeger P; Cohen-Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Arch Mal Coeur Vaiss; 1988 Feb; 81(2):157-62. PubMed ID: 2967069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sympathetic nervous system in heart failure: effect of catecholamines and nitric oxide].
    Drexler H
    Z Kardiol; 1996; 85 Suppl 6():247-52. PubMed ID: 9064972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system.
    Teerlink JR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S1-8. PubMed ID: 8723392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.
    Guazzi MD; Agostoni P; Perego B; Lauri G; Salvioni A; Giraldi F; Matturri M; Guazzi M; Marenzi G
    Br Heart J; 1994 Dec; 72(6):534-9. PubMed ID: 7857735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the sympathetic nervous system and electrolytes in congestive heart failure.
    Francis GS
    Am J Cardiol; 1990 Mar; 65(10):24E-27E; discussion 52E. PubMed ID: 2309625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurohumoral interactions in conscious dehydrated rabbit.
    Trapani AJ; Undesser KP; Keeton TK; Bishop VS
    Am J Physiol; 1988 Feb; 254(2 Pt 2):R338-47. PubMed ID: 3278629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of renal denervation in the treatment of heart failure.
    Sobotka PA; Krum H; Böhm M; Francis DP; Schlaich MP
    Curr Cardiol Rep; 2012 Jun; 14(3):285-92. PubMed ID: 22392370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence against an interaction of angiotensin II with the sympathetic nervous system in man.
    Nicholls MG; Espiner EA; Miles KD; Zweifler AJ; Julius S
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):423-30. PubMed ID: 7035012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of vasopressin in experimental heart failure.
    Riegger AJ
    Eur Heart J; 1988 Jun; 9 Suppl H():7-10. PubMed ID: 3049096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyponatremia in congestive heart failure: implications for neurohumoral activation and responses to orthostasis.
    Lilly LS; Dzau VJ; Williams GH; Rydstedt L; Hollenberg NK
    J Clin Endocrinol Metab; 1984 Nov; 59(5):924-30. PubMed ID: 6384261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine manifestations of congestive heart failure.
    Francis GS
    Am J Cardiol; 1988 Jul; 62(2):9A-13A. PubMed ID: 3291596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma arginine vasopressin levels in patients with congestive heart failure.
    Goldsmith SR; Francis GS; Cowley AW; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Jun; 1(6):1385-90. PubMed ID: 6343460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.